NCT01159808View on ClinicalTrials.gov

A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

October 31, 2010

Conditions
Healthy
Interventions
DRUG

INX-08189

3, 25 and 100 mg capsules; oral administration, single dose

DRUG

Placebo

matching placebo capsules, oral administration, single dose

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY